Skip to content
Screener

Neogen NEOG Total Revenue

Total Revenue at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$11.99B
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.22B+9.7%
Zoetis logo
ZoetisZTS
$2.47B-0.2%
Revvity logo
RevvityRVTY
$711.12M+7.0%
Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
TEC
Bio-TechneTECH
$311.42M-1.5%

Segments

By product

See full
Indicator Testing And Culture Media$83M
Bacterial And General Sanitation$42.1M+5.5%
Genomics Services$22.8M+0.4%
Biosecurity Products$18.9M-46.9%
Natural Toxins And Allergens$17.9M+1.7%
Veterinary Instruments And Disposables$15.5M0.0%

By segment

See full
Food Safety$156.7M+2.6%
Animal Safety$54.5M-20.1%

By geography

See full
US$86.37M

Other financials

Income statement

See full
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.49B+140%
Enterprise value$3.12B+71.2%
P/S2.9×+1.7×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
Line itemThree months ended February 28, 2026Three months ended February 28, 2025Nine months ended February 28, 2026Nine months ended February 28, 2025
Revenues
Product revenues$186.2$196.5$569.4$596.6
Service revenues25.024.575.772.6
Total Revenues211.2221.0645.1669.2
Cost of Revenues
Cost of product revenues96.095.8296.6293.5
Cost of service revenues16.214.947.847.2
Total Cost of Revenues112.2110.7344.4340.7

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's total revenue?
Neogen (NEOG) reported total revenue of $211.2M in Q4 2025.
How has Neogen's total revenue changed year-over-year?
Neogen's total revenue decreased by 4.4% year-over-year, from $221M to $211.2M.
What is the long-term trend for Neogen's total revenue?
Over 3 years (2022 to 2025), Neogen's total revenue has grown at a 19.3% compound annual growth rate (CAGR), from $527.16M to $894.68M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Neogen's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude